Stephen C. Hadler

13.7k citations

136 papers · 8.5k indexed · 5 hit papers · h-index 46

Epidemiology top 0.2%
Hepatology top 0.1%
Infectious Diseases top 0.5%
Health top 0.2%
Microbiology top 0.5%

Co-authors: Harold S. Margolis James E. Maynard Miriam J. Alter Beth P. Bell Susan E. Reef Fangjun Zhou Susan T. Goldstein Eric E. Mast
Topics: Hepatitis B Virus Studies (59 papers)Hepatitis Viruses Studies and Epidemiology (44 papers)Vaccine Coverage and Hesitancy (41 papers)
Cited by: Hepatology Health Epidemiology
Journals: New England Journal of Medicine JAMA Annals of Internal Medicine
Partner nations: United States China Switzerland

In The Last Decade

Stephen C. Hadler

135 papers receiving 7.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.

2014 549 citations Stephen C. Hadler et al. PubMed profile →
A mathematical model to estimate global hepatitis B disease burden and vaccination impact

2005 538 citations Stephen C. Hadler, Harold S. Margolis et al. profile →
Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men

1986 502 citations Stephen C. Hadler, James E. Maynard et al. profile →
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

2021 371 citations Julia W. Gargano, Megan Wallace et al. profile →
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

2021 130 citations Karen R. Broder, Julia W. Gargano et al. profile →

Peers

Countries citing papers authored by Stephen C. Hadler

Since Specialization

Citations

This map shows the geographic impact of Stephen C. Hadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Hadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Hadler more than expected).

Fields of papers citing papers by Stephen C. Hadler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Hadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Hadler. The network helps show where Stephen C. Hadler may publish in the future.

Co-authorship network of co-authors of Stephen C. Hadler

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Hadler. A scholar is included among the top collaborators of Stephen C. Hadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Hadler. Stephen C. Hadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States 2023 ·Vaccine ·Megan Wallace,Hannah G. Rosenblum,Danielle Moulia,Karen R. Broder,Tom T. Shimabukuro,Christopher A. Taylor,Fiona P. Havers,Sarah Meyer,Kathleen Dooling,Sara E. Oliver,Stephen C. Hadler,Julia W. Gargano	11
2	The Brighton collaboration standardized module for vaccine benefit-risk assessment 2023 ·Vaccine ·Bennett Levitan,Stephen C. Hadler,William Hurst,Héctor S. Izurieta,Emily Smith,Nicole L. Baker,Vincent Bauchau,Rebecca E. Chandler,Robert T. Chen,(unknown),(unknown),Punnee Pitisuttithum,(unknown),(unknown),(unknown),Sonali Kochhar	5
3	A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007- June 2012 2015 ·PLoS ONE ·(unknown),Yi Tan,Virasakdi Chongsuvivatwong,Xinghua Wu,(unknown),Stephen C. Hadler,Chuleeporn Jiraphongsa,(unknown),Mei Lin,Yi Quan	20
4	The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization 2013 ·Vaccine ·M. Kane,Stephen C. Hadler,(unknown),Craig N. Shapiro,(unknown),(unknown),Rajeev Kumar	37
5	Origins, design and implementation of the China GAVI project 2013 ·Vaccine ·Xiaofeng Liang,Fuqiang Cui,Stephen C. Hadler,Xiaojun Wang,Huiming Luo,Yuansheng Chen,Mark Kane,Craig Shapiro,Weizhong Yang,Yu Wang	30
6	Evaluation of immunization injection safety in China, 2010: Achievements, future sustainability 2013 ·Vaccine ·Zhenhua Wu,Fuqiang Cui,Yuansheng Chen,Ning Miao,Xiao-hong Gong,Huiming Luo,Fuzhen Wang,(unknown),Mark Kane,Stephen C. Hadler,Yvan Hutin,Xiaofeng Liang,Weizhong Yang	14
7	The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. 1997 ·American Journal of Public Health ·Jessica Tuttle,(unknown),Heikki Rantala,James D. Cherry,Phillip Rhodes,Stephen C. Hadler	50
8	Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the Amerii Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association 1997 ·Journal of School Health ·Francisco Averhoff,Walter W. Williams,Stephen C. Hadler	6
9	Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States 1997 ·PEDIATRICS ·Robert T. Chen,John W. Glasser,Philip Rhodes,Robert L. Davis,William E. Barlow,Robert S. Thompson,John P. Mullooly,Steven Black,Henry R. Shinefield,Constance M. Vadheim,S. Michael Marcy,Joel I. Ward,Robert P. Wise,Steven G.F. Wassilak,Stephen C. Hadler,(unknown)	281
10	Measles vaccination levels of children enrolled in WIC during the 1991 measles epidemic in New York City. 1996 ·American Journal of Public Health ·Charles W. LeBaron,Guthrie S. Birkhead,(unknown),John C. Grabau,(unknown),(unknown),Steven C. Brooks,(unknown),Stephen Friedman,Stephen C. Hadler	11
11	The immunization of children enrolled in the Special Supplemental Food Program for Women, Infants, and Children (WIC). The impact of different strategies. 1995 ·PubMed ·Guthrie S. Birkhead,Charles W. LeBaron,(unknown),John C. Grabau,(unknown),(unknown),(unknown),Steven C. Brooks,Jorge Rosenthal,Stephen C. Hadler	53
12	Utility of Large‐linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic Effects 1995 ·Annals of the New York Academy of Sciences ·Steven G. F. Wassilak,John W. Glasser,Robert T. Chen,Stephen C. Hadler,(unknown)	35
13	Successes and Failures in Vaccine Delivery: Evaluation of the Immunization Delivery System in Puerto Rico 1993 ·PEDIATRICS ·(unknown),Felicity T. Cutts,(unknown),(unknown),(unknown),Stephen C. Hadler,(unknown)	33
14	Hepatitis B vaccination programs for health care personnel in U.S. hospitals. 1991 ·PubMed ·(unknown),(unknown),Walter W. Williams,Stephen C. Hadler,Jonathan White,(unknown)	9
15	Hepatitis B: Evolving Epidemiology and Implications for Control 1991 ·Seminars in Liver Disease ·Harold S. Margolis,Miriam J. Alter,Stephen C. Hadler	328
16	Immunogenicity of Low-Dose Intradermal Recombinant DNA Hepatitis B Vaccine 1991 ·Southern Medical Journal ·David C. Parish,(unknown),(unknown),(unknown),Stephen C. Hadler	14
17	Foodborne Hepatitis A: Evidence that Microwaving Reduces Risk? 1990 ·The Journal of Infectious Diseases ·Ban Mishu,Stephen C. Hadler,(unknown),Robert H. Hutcheson,John M. Horan,William Schaffner	13
18	THE EPIDEMIOLOGY OF HEPATITIS B VIRUS AMONG FAMILY MEMBERS IN THE MIDDLE EAST 1990 ·American Journal of Epidemiology ·Ala U. Toukan,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Stephen C. Hadler,Harold S. Margolis,(unknown),James E. Maynard	73
19	Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization 1989 ·Clinical Infectious Diseases ·James E. Maynard,Mark Kane,Stephen C. Hadler	123
20	Delta hepatitis in homosexual men in the united states 1989 ·Hepatology ·Isaac B. Weisfuse,Stephen C. Hadler,Howard A. Fields,Miriam J. Alter,(unknown),Franklyn N. Judson,David G. Ostrow,(unknown)	10

About Stephen C. Hadler

Stephen C. Hadler is a scholar working on Hepatology, Health and Epidemiology, having authored 136 papers that have together received 8.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (59 papers), Hepatitis Viruses Studies and Epidemiology (44 papers) and Vaccine Coverage and Hesitancy (41 papers). The work is most often cited by research in Hepatology (3.4k citations), Health (1.9k citations) and Epidemiology (5.6k citations). Stephen C. Hadler has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Harold S. Margolis, James E. Maynard, Miriam J. Alter, Beth P. Bell, Susan E. Reef, Fangjun Zhou, Susan T. Goldstein, Eric E. Mast, Clare A. Dykewicz and Lynette Phillips. Their work appears in journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact